Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!

Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.

Garrett Winslow Biography and Net Worth

General Counsel of Galecto

Presently, Garrett M. Winslow holds the position of Senior Vice President & General Counsel of Galecto, Inc.

In his past career he was Principal at Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC and Secretary, Vice President-Legal & General Counsel at Spring Bank Pharmaceuticals, Inc.

Garrett M. Winslow received a graduate degree from Boston University School of Law, a graduate degree from Suffolk University Law School and an undergraduate degree from the University of Washington.

What is Garrett Winslow's net worth?: The estimated net worth of Garrett Winslow is at least $4,190.63 as of November 20th, 2020. Mr. Winslow owns 6,250 shares of Galecto stock worth more than $4,191 as of April 25th. This net worth evaluation does not reflect any other investments that Mr. Winslow may own. Learn More about Garrett Winslow's net worth.
How old is Garrett Winslow?: Mr. Winslow is currently 45 years old. There are 2 older executives and no younger executives at Galecto. The oldest executive at Galecto is Dr. Hans T. Schambye M.D., Ph.D., Co-Founder, President, CEO & Director, who is 58 years old. Learn More on Garrett Winslow's age.
How do I contact Garrett Winslow?: The corporate mailing address for Mr. Winslow and other Galecto executives is GALECTO BIOTECH AB OLE MAALOES VEJ3, COPENHAGEN G7, DK-2200. Galecto can also be reached via phone at 45-7070-5210. Learn More on Garrett Winslow's contact information.
Has Garrett Winslow been buying or selling shares of Galecto?: Garrett Winslow has not been actively trading shares of Galecto within the last three months. Most recently, on Friday, December 3rd, Garrett Winslow bought 2,000 shares of Galecto stock. The stock was acquired at an average cost of $2.48 per share, with a total value of $4,960.00. Learn More on Garrett Winslow's trading history.
Who are Galecto's active insiders?: Galecto's insider roster includes Jonathan Freve (CFO), Bertil Lindmark (Insider), Hans Schambye (CEO), and Garrett Winslow (General Counsel). Learn More on Galecto's active insiders.
Are insiders buying or selling shares of Galecto?: In the last year, insiders at the sold shares 3 times. They sold a total of 443,300 shares worth more than $1,209,944.00. The most recent insider tranaction occured on July, 31st when Major Shareholder Orbimed Advisors Llc sold 209,400 shares worth more than $628,200.00. Insiders at Galecto own 12.1% of the company. Learn More about insider trades at Galecto.
Information on this page was last updated on 7/31/2023.

Garrett Winslow Insider Trading History at Galecto

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
12/3/2021	Buy	2,000	$2.48	$4,960.00

Garrett Winslow Buying and Selling Activity at Galecto

Galecto Company Overview

Galecto, Inc., a clinical-stage biotechnology company, develops molecules for the treatment of fibrosis, cancer, inflammation, and other related diseases. The company's lead product candidate is GB2064, which is in Phase IIa for the treatment of myelofibrosis. It also develops GB0139, an inhaled small molecule inhibitor of galectin-3 that is in Phase IIb clinical trial for the treatment of fibrotic lung diseases, such as idiopathic pulmonary fibrosis, a life-threatening progressive fibrotic disease of the lung; GB2064, a selective oral small molecule inhibitor of LOXL2 that is in Phase 2a clinical trial for the treatment of myelofibrosis; and GB1211, a selective oral galectin-3 inhibitor that is in Phase IIa for the treatment of cancer, as well as in Phase Ib/IIa for fibrosis. Galecto, Inc. was founded in 2011 and is headquartered in Copenhagen, Denmark.

Today's Range

Now: $0.67

$0.65

$0.70

50 Day Range

MA: $0.74

$0.66

$0.89

2 Week Range

Now: $0.67

$0.50

$3.70

Volume

26,332 shs

Average Volume

226,256 shs

Market Capitalization

$18.09 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.24

Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!

From Priority Gold | Ad

Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.

Click here for your free guide

Garrett Winslow Biography and Net Worth

What is Garrett Winslow's net worth?

How old is Garrett Winslow?

How do I contact Garrett Winslow?

Has Garrett Winslow been buying or selling shares of Galecto?

Who are Galecto's active insiders?

Are insiders buying or selling shares of Galecto?